Yábar-Villafuerte G, Becerra-Quiñones Y, Obando-Pereda GA

Language: Spanish
References: 13
Page: 100-103
PDF size: 299.85 Kb.

ABSTRACT

Introduction: Chronic periapical lesions cause bone defects in the apical area of compromised teeth. Standard therapy requires osteotomy, apex removal and profuse curettage to remove granulomatous and infected tissue, thus leaving a bone defect in its wake. Report of two cases: Two patients with periapical lesions were subjected to apicoectomy procedure where fibrin-rich plasma was placed as bone filling. Treatment was effective, since after 30 days a radio opaque area was radiographically observed, suggesting bone formation. Conclusion: Use of fibrin-rich plasma as bone filling after paraendodontic surgeries could represent a suitable alternative to commercial bone fillings, due to its bone induction properties.

REFERENCES

1. Del Fabbro M, Corbella S, Sequeira-Byron P, Tsesis I, Rosen E, Lolato A, et al. Endodontic procedures for retreatment of periapical lesions. Cochrane Database Syst Rev. 2016; 10: CD005511.

2. Del Fabbro M, Samaranayake LP, Lolato A, Weinstein T, Taschieri S. Analysis of the secondary endodontic lesions focusing on the extraradicular microorganisms: an overview. J Investig Clin Dent. 2014; 5 (4): 245-254.

3. Vaishnavi C, Mohan B, Narayanan LL. Treatment of endodontically induced periapical lesions using hydroxyapatite, platelet-rich plasma, and a combination of both: An in vivo study. J Conserv Dent. 2011; 14 (2): 140-146.

4. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J. 2001; 10 Suppl 2: S96-S101.

5. Zizzari VL, Zara S, Tetè G, Vinci R, Gherlone E, Cataldi A. Biologic and clinical aspects of integration of different bone substitutes in oral surgery: a literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122 (4): 392-402.

6. Obando-Pereda GA. Autologus barriers, fillers and growing factors: using the secondary pathway of haemostasis in dental clinics-report of four clinical cases. J Dental Sci. 2016, 1 (2): 000107.

7. Dohan-Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB. Choukroun’s platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol. 2010; 55 (3): 185-194.

8. Karunakar P, Prasanna JS, Jayadev M, Shravani GS. Platelet-rich fibrin, “a faster healing aid” in the treatment of combined lesions: a report of two cases. J Indian Soc Periodontol. 2014; 18 (5): 651-655.

9. Pradeep AR, Nagpal K, Karvekar S, Patnaik K, Naik SB, Guruprasad CN. Platelet-rich fibrin with 1% metformin for the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial. J Periodontol. 2015; 86 (6): 729-737.

10. Jadhav GR, Shah D, Raghvendra SS. Autologus platelet rich fibrin aided revascularization of an immature, non-vital permanent tooth with apical periodontitis: a case report. J Nat Sci Biol Med. 2015; 6 (1): 224-225.

11. Nagaveni NB, Kumari KN, Poornima P, Reddy V. Management of an endo-perio lesion in an immature tooth using autologous platelet-rich fibrin: a case report. J Indian Soc Pedod Prev Dent. 2015; 33 (1): 69-73.

12. Gupta SJ, Jhingran R, Gupta V, Bains VK, Madan R, Rizvi I. Efficacy of platelet-rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: a clinical and cone beam computed tomography study. J Int Acad Periodontol. 2014; 16 (3): 86-96.

13. Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg. 2008; 66 (4): 616-624.